Literature DB >> 26525658

Vagal efferent stimulation protects against Mesobuthus tamulus venom-induced acute respiratory distress syndrome in rats.

Aparna Akella1, Shripad B Deshpande2.   

Abstract

Mesobuthus tamulus (MBT) venom and oleic acid (OA) have been shown to produce acute respiratory distress syndrome (ARDS) involving different mechanisms. The role of vagally mediated anti-inflammatory pathway in ARDS is poorly understood. Therefore, the effects of vagal efferent stimulation on these two models of ARDS were examined. Experiments were performed on anesthetized adult rats. Parameters like ventilatory changes (respiratory frequency and minute ventilation), hypoxemic status (PaO2/FiO2 ratio; P/F ratio), survival time, pulmonary water content and histopathological evidences of lung injury were determined to assess the severity of ARDS. In addition, heart rate (HR) and mean arterial pressure (MAP) were monitored. Injection of OA/MBT venom produced respiratory alterations, hypoxemia, pulmonary edema and histopathological changes demonstrating the development of ARDS. In both the groups, animals died around 60 min. Tachypnea and hyperventilation were seen after OA while bradypnea and hypoventilation were seen after MBT venom. Pulmonary edema was absent in vagotomised animals in MBT venom group but not in OA group. Further, electrical stimulation of the cut peripheral ends of vagii prolonged the survival time and attenuated all the parameters of MBT venom-induced ARDS significantly. In case of OA, there was improvement in histopathological changes but the survival time of animals was not prolonged. Stimulation of α7-nicotinic receptors (by pretreatment with GTS-21) exacerbated OA as well as MBT venom-induced ARDS. The present results indicate that vagal efferent stimulation protects against MBT venom-induced ARDS.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Anti-inflammatory pathway; Hypoxemia; Oleic acid; Pulmonary edema; α7 nicotinic receptors

Mesh:

Substances:

Year:  2015        PMID: 26525658     DOI: 10.1016/j.toxicon.2015.10.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  HMGB1: A Potential Target of Nervus Vagus Stimulation in Pediatric SARS-CoV-2-Induced ALI/ARDS.

Authors:  Lina Jankauskaite; Mantas Malinauskas; Goda-Camille Mickeviciute
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

Review 2.  Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease.

Authors:  Svetlana Mastitskaya; Nicole Thompson; David Holder
Journal:  Front Neurosci       Date:  2021-04-13       Impact factor: 4.677

3.  Vagus nerve stimulation enhances the cholinergic anti-inflammatory pathway to reduce lung injury in acute respiratory distress syndrome via STAT3.

Authors:  Sheng Li; Di Qi; Jia-Ni Li; Xin-Yu Deng; Dao-Xin Wang
Journal:  Cell Death Discov       Date:  2021-03-29

4.  Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.

Authors:  Rahma Ben Abderrazek; Ayoub Ksouri; Faten Idoudi; Sayda Dhaouadi; Emna Hamdi; Cécile Vincke; Azer Farah; Zakaria Benlasfar; Hafedh Majdoub; Mohamed El Ayeb; Serge Muyldermans; Balkiss Bouhaouala-Zahar
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.